Heron Therapeutics (HRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2009 | 12-2008 | 12-2007 | 12-2006 | 12-2005 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -10,028 | -23,125 | -20,163 | 5,266 | -8,210 |
| Depreciation Amortization | 356 | 412 | 289 | -244 | 446 |
| Accounts receivable | -139 | 100 | -149 | 1,369 | -83 |
| Accounts payable and accrued liabilities | -182 | -1,093 | 665 | 158 | -83 |
| Other Working Capital | -2,449 | -2,978 | 2,092 | 3,494 | -59 |
| Other Operating Activity | 1,443 | 2,409 | -15 | -862 | 462 |
| Operating Cash Flow | $-10,999 | $-24,275 | $-17,281 | $9,181 | $-7,527 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 614 | 976 | 11,683 | -7,530 | 5,404 |
| PPE Investments | 2 | -298 | -481 | -187 | -316 |
| Other Investing Activity | -4 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $612 | $678 | $11,202 | $-7,717 | $5,088 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 8,013 | 54 | 37,256 | 79 | 119 |
| Financing Cash Flow | $8,013 | $54 | $37,256 | $79 | $119 |
| Beginning Cash Position | 9,967 | 33,510 | 2,333 | 790 | 3,110 |
| End Cash Position | 7,593 | 9,967 | 33,510 | 2,333 | 790 |
| Net Cash Flow | $-2,374 | $-23,543 | $31,177 | $1,543 | $-2,320 |
| Free Cash Flow | |||||
| Operating Cash Flow | -10,999 | -24,275 | -17,281 | 9,181 | -7,527 |
| Capital Expenditure | 2 | -298 | -481 | -187 | -316 |
| Free Cash Flow | -10,997 | -24,573 | -17,762 | 8,994 | -7,843 |